Fausto N
Biochem J. 1972 Oct;129(4):811-20. doi: 10.1042/bj1290811.
The release of (14)CO(2) from [7-(14)C]orotic acid was measured in isolated perfused normal and regenerating rat livers. With some limitations, the release of (14)CO(2) from [7-(14)C]orotic acid can be used to estimate UMP synthesis in perfused livers. Isolated perfused livers rapidly pick up labelled orotic acid added to perfusate and convert most of it into UMP. Perfused regenerating livers produce approx. 2.5 times as much UMP/g of liver as do perfused normal livers. However, the absolute amount of orotic acid converted into UMP is higher in perfused normal livers than in perfused regenerating livers. Perfused regenerating livers do not differ in their orotic acid uptake and UMP synthesis from livers of comparable size in which regeneration is not taking place. The total amount of orotic acid taken up by the liver (rather than the rate of uptake) and the size of the liver appear to be the determining factors in UMP production. The results suggest that the decrease in liver size caused by partial hepatectomy may be in itself sufficient to account for an increase in the flow of metabolites in the pyrimidine pathway at the early stages of liver regeneration.
在分离灌注的正常和再生大鼠肝脏中,测定了[7-(14)C]乳清酸释放(14)CO(2)的情况。尽管存在一些局限性,但[7-(14)C]乳清酸释放(14)CO(2)的情况可用于估算灌注肝脏中UMP的合成。分离灌注的肝脏能迅速摄取添加到灌注液中的标记乳清酸,并将其大部分转化为UMP。灌注的再生肝脏产生的UMP/克肝脏量约为灌注正常肝脏的2.5倍。然而,转化为UMP的乳清酸绝对量在灌注正常肝脏中高于灌注再生肝脏。灌注的再生肝脏在乳清酸摄取和UMP合成方面与未发生再生的同等大小肝脏并无差异。肝脏摄取的乳清酸总量(而非摄取速率)和肝脏大小似乎是UMP产生的决定因素。结果表明,部分肝切除引起的肝脏体积减小本身可能足以解释肝脏再生早期嘧啶途径中代谢物流量的增加。